1. Contracts ending soon
  2. Office of Assistant Secretary for Preparedness and Response
  3. NAICS 541715

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) contracts ending at Office of Assistant Secretary for Preparedness and Response

Department of Health and Human Services

19 contracts of $100,000 or more under NAICS 541715, research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology), at Office of Assistant Secretary for Preparedness and Response end in the next 18 months, with $42M obligated so far. 9 end within six months, so their follow-on may already be in the works.

Ending in 18 months
19 contracts$42M obligated so far
Biggest holder
Safesource Direct LLC$145M on 1 contract ending soon
Open notices
NAICS 541715contract opportunities open now
Source
USAspending.govUpdated Nov 17, 2026, 7:37 PM UTC

Contracts ending soon

Soonest end first. Each contract links to its record on USAspending.gov.

ContractObligatedEndsState
Industrial Base Expansion of NbrSafesource Direct LLC · 75A50223C00024$144,763,969Dec 15, 2026within a monthLA
Development of Hopo-101 As an Mcm (Medical Countermeasure) Decorporation Agent for the Treatment of Individuals With Known or Suspected Internal Contamination With Radionuclides (the ?mcm…Hopo Therapeutics, Inc. · 75A50124C00062$14,209,253Dec 31, 2026in 1 monthCA
The Scope of Work for This Contract Includes Preclinical, Regulatory, and Manufacturing Development Activities.Keranetics Inc. · 75A50122C00017$5,322,273Dec 31, 2026in 1 monthNC
Brite Stored H5N1 Influenza Vaccine Trial With and Without Adjuvant Protocol Csn 15-0001American Type Culture Collection · 75A50121F33003$316,582Jan 11, 2027in 1 monthVA
Storage and Distribution of Specimens, Up to Bsl-3 Select Agents and Non-Select AgentsAmerican Type Culture Collection · 75A50123F33007$901,962Jan 18, 2027in 2 monthsVA
Accuro Xv Product for Rapid, Ultrasound Based, Radiation-Free, Bedside Fracture Triage. This Device Will Reduce Bottlenecks in Mass Casualty Blast Trauma Incidents.Rivanna Medical, Inc. · 75A50121C00035$52,055,826Mar 31, 2027in 4 monthsVA
Integrated Safety Summary Report of Clinical Studies Assessing Safety of Influenza Vaccines Administered With AS03 or MF59 Adjuvant.Rho Federal Systems Division Inc · 75A50122F33004$2,983,502Mar 31, 2027in 4 monthsNC
Industrial Base Expansion (Ibx) for Methacrylic Acid for Key Chemicals.Qyk Brands LLC · 75A50424C00001$48,315,610Apr 16, 2027in 4 monthsCA
Bsl-4 Level Storage for Filovirus StocksAmerican Type Culture Collection · 75A50122F33006$875,166Apr 28, 2027in 5 monthsVA
Advance the Development of PAAG17G (Drug Product: MIIST305), a Once Daily, Orally Administered, Gut-Restricted Drug, to Reduce Mortality and Morbidity Arising From Acute Exposure to Ionizing…Synedgen, Inc. · 75A50124C00047$18,828,663May 31, 2027in 6 monthsCA
Aspr-21-02385- Atcc (Bsip) - Storage of H7N9 Legacy Samples Under Protocol BPI7002 Contract 75A50120D00013 33004American Type Culture Collection · 75A50121F33004$119,982Aug 23, 2027in 9 monthsVA
Bioaegis: Plasma Gelsolin (Pgsn), an Abundant, Circulating Protein Modulates Inflammation While Also Enhancing Host Defenses by Stimulating the Uptake and Killing of Pathogens. Clinical Studies…Bioaegis Therapeutics Inc · 75A50123C00067$20,000,000Aug 31, 2027in 9 monthsNJ
Anthrax AV7909 Boost Evaluation and Antigen-Sparing Trial (Abeast)Rho Federal Systems Division Inc · 75A50122F33003$3,834,161Sep 18, 2027in 10 monthsNC
Contract Award to Further Develop the Beacon Model in a Series of Sequential Updates, Including Incorporating Recent Data Inputs, Augmenting the Outpatient Model Structure, and, If Data Permit…Iqvia Government Solutions Inc · 75A50124C00029$3,322,007Sep 30, 2027in 10 monthsVA
Atcc Task Order: Ieidd Biological, Specimen Receipt, Processing, Storage and Distribution ServicesAmerican Type Culture Collection · 75A50126F33009$327,251Sep 30, 2027in 10 monthsVA
GEN1E - This Contract Will Provide Support to GEN1E Lifesciences Inc. (GEN1E), a US Company, for the Advancement of Patient Stratification and Endotyping Approaches As IT Develops Gen-1124, a Novel…GEN1E Lifesciences Inc. · 75A50123C00063$749,000Dec 30, 2027in 13 monthsCA
This System Would Be Used and Integrated Within Routine Care for Burns and Traumatic Injuries, But Would Also Have the Potential to Be of Use in Detection Viral Pneumonia of Covid 19 Cases.Philips North America LLC · 75A50120C00097$68,166,641Dec 31, 2027in 13 monthsMA
Base Period Award Human Organ Tissue Equivalent Models of Fibrosing Chemical Exposure to Bridge Preclinical and Clinical Translation of Medical CountermeasuresWake Forest University Health Sciences · 75A50124C00044$22,092,307Jan 31, 2028in 14 monthsNC
Partner Therapeutics: the Overall Objective of This Contract Is to Confirm Leukine Safety in Sepsis Patients, Inform Optimal Leukine Dosing, Explore Leukine Efficacy, As Well As Advance Development…Partner Therapeutics, Inc. · 75A50124C00061$12,990,717Mar 31, 2028in 16 monthsMA

End dates are the current period of performance; options not yet exercised can extend them. An ending contract may be competed again, extended, or moved to another vehicle. BPA calls and orders shorter than six months are left out. Department of Defense contracts appear on USAspending.gov about 90 days after award.

Get new notices under NAICS 541715

New contract opportunities under NAICS 541715, research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology), the morning they appear. Free while in beta.

Free. We use your email only for these alerts and never share it. Privacy